Assessment of response of chronic phase CML to imatinib treatment /
Ashraf Ata Elfotouh
Assessment of response of chronic phase CML to imatinib treatment / تقييم الاستجابة فى مرضى سرطان الدم المزمن من النوع الميلومى - المرحلة المزمنة - لعقار ايماتينيب Ashraf Ata Elfotouh ; Supervised Wafaa Elmetnawy , Hamdy M.Zawam , Ahmed Selim - Cairo : Ashraf Ata Elfotouh , 2007 - 118P. ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Oncology
The cause of chronic myeloid leukemia is a constitutively active BCR - ABL tyrosine kinase , imatinib inhibits this kinease
Chronic myeloid leukemia Chronic phase Philadelphia chromosome positive
Assessment of response of chronic phase CML to imatinib treatment / تقييم الاستجابة فى مرضى سرطان الدم المزمن من النوع الميلومى - المرحلة المزمنة - لعقار ايماتينيب Ashraf Ata Elfotouh ; Supervised Wafaa Elmetnawy , Hamdy M.Zawam , Ahmed Selim - Cairo : Ashraf Ata Elfotouh , 2007 - 118P. ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Oncology
The cause of chronic myeloid leukemia is a constitutively active BCR - ABL tyrosine kinase , imatinib inhibits this kinease
Chronic myeloid leukemia Chronic phase Philadelphia chromosome positive